The News
Sofinnova Partners and Sofinnova Ventures Host Inaugural CEO Day Conference
20/03/2003
Over 40 CEOs from Europe and the US came together on the island of Corsica for a trans-Atlantic meeting of the minds
We're pleased to announce that we recently held our inaugural Sofinnova CEO Conference, which we co-hosted with Sofinnova Ventures of San Francisco from March 20-22. Our goal was to provide our CEOs with constructive and thought-provoking workshops, as well as the opportunity to network with an international peer group. The conference brought unique trans-Atlantic value to our portfolio companies.
The event was a real success. Despite the coinciding outbreak of war, 43 CEOs from Europe and the US flew to Corsica to attend the 2-day event. Special guests who addressed the group included information technology keynote Jean-Francois Pontal, CEO of European telecommunications giant Orange SA; life science keynote Jean-Pierre Garnier, CEO of GlaxoSmithKline; Ken Alwyn, a senior partner in PricewaterhouseCoopers' global organization; and Marco Landi, former president of BMC Europe, former COO of Apple Computer and former president of Texas Instruments Europe.
The CEOs discussed their business challenges and shared best practices regarding critical business issues such as surviving in an adverse economic environment, development of a global strategy, strategic business plan development, optimal sales force management, development of a customer-focused organization, corporate governance, and, of course, "managing your board."
We will host CEO conferences annually, alternating the locale between Europe and the U.S.
2003
- 25/02/2003
-
20/03/2003
Sofinnova Partners and Sofinnova Ventures Host Inaugural CEO Day Conference
- 17/04/2003
- 28/04/2003
- 02/05/2003
-
14/05/2003
Novuspharma SpA Announces Financial Results for the Three Months Ended 31 March 2003
-
05/06/2003
Jean-Bernard Schmidt elected as Association Chairman in 20th year of EVCA
- 05/06/2003
- 05/06/2003
- 17/06/2003
-
07/07/2003
NovusPharma’s Pixantrone Regimen produces high response rates in relapsed aggressive lymphoma
-
28/07/2003
Servista enables Lloyds TSB to launch home energy and telephone services
-
07/08/2003
Novuspharma SpA Announces Financial Results for the Six Months Ended 30 June 2003
- 30/06/2003
-
02/09/2003
Ingenium Appoints Dr. Klaus Dembowsky to Vice President Drug Discovery
- 10/09/2003
-
30/09/2003
Novuspharma Press Release: Financial Results for the nine months ended 30 September 2003
-
23/10/2003
Cell Therapeutics, Inc. and Novuspharma S.p.A Announce Shareholder Approval of Merger
-
28/10/2003
Cellzome Announces Research Collaboration with Johnson & Johnson R&D
- 13/11/2003
- 25/11/2003
-
14/11/2003
Innate Pharma and Novo Nordisk A/S sign licensing deal which opensnew avenue in cancer immunotherapy
- 19/11/2003
-
19/11/2003
Allergan and Exonhit designate target for high throughput screening
-
02/12/2003
The pharmaceutical company Biolipox strengthens Board of Directors with a well known industrialist
-
10/12/2003
Addex Pharmaceuticals SA Signs Three year Clinical Development Partnership with Fulcrum Pharma
- 12/12/2003
- 29/12/2003
- 19/12/2003
- 19/12/2003